Your session is about to expire
← Back to Search
Inhaled treprostinil solution for Chronic Obstructive Pulmonary Disease (PERFECT Trial)
PERFECT Trial Summary
This trial is testing if inhaled treprostinil can help improve exercise ability in people with PH-COPD, as measured by how far they can walk in 6 minutes.
- Chronic Obstructive Pulmonary Disease
- Pulmonary Hypertension
PERFECT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PERFECT Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any harmful effects to inhaling treprostinil solution?
"There is some clinical evidence to support inhaled treprostinil solution's efficacy, so it received a score of 3."
If Inhaled treprostinil solution has undergone clinical trials before, where can I find information about those?
"inhaled treprostinil solution was first studied in the year 2015 at Arkansas Children's Hospital. So far, there have been 69 completed trials and 9 that are still recruiting participants. Most of these active studies are based in Boston, Massachusetts."
What are the primary conditions that Inhaled treprostinil solution has been shown to improve?
"Treprostinil solution, which is delivered through inhalation, is most often used to improve the symptoms of patients with Nyha functional class III pulmonary arterial hypertension. Additionally, this medication can be given to patients suffering from other conditions like WHO functional class II-III pulmonary arterial hypertension."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
Share this study with friends
Copy Link
Messenger